PLAU and ovarian carcinoma: More recently, a study demonstrated that CXCL12 strongly induced αvβ6 integrin expression in ovarian cancer, leading to enhanced urokinase plasminogen activator (uPA)-mediated ECM degradation and cell invasion [69].